Clinical Trials Q1 2021
-
s Sponsored
Improving outcomes for neurology clinical trials
Clinical trials in neurological diseases are a complex area of research where figures suggest there is an unusually high failure rate. Data from the United States shows that only 5.9% of phase I neurology clinical trial drugs are likely to get FDA approval and of the 2,352 neurology clinical trials started in 2020, fewer than...
-
Re-evaluating clinical trials to ensure their effective progress
Strengthening clinical trial capabilities and infrastructure is key to yielding actionable data. The COVID-19 pandemic has posed challenges to the conduct of all clinical trials, including those for COVID-19. To advise investigators during the pandemic, the Food and Drug Administration (FDA) issued guidance on how best to adapt trials, including recommendations on the use of virtual visits and methods for secure delivery of medications. The agency also issued guidance...
Global Cause